You are here

Innate Pharma

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer

BioSpace

Mon, 04/22/24 - 11:27 am

FDA Puts Innate’s Lymphoma Trials on Partial Hold After Patient Death

BioSpace

Thu, 10/5/23 - 11:45 am

Takeda taps Innate for a new celiac approach

EP Vantage

Thu, 04/13/23 - 09:58 am

antibody-drug conjugate

Takeda opens 4th front in assault on celiac, tapping Innate to develop antibody-drug conjugates

Fierce Biotech

Mon, 04/3/23 - 09:44 am

antibody-drug conjugate

Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers

Fierce Biotech

Mon, 12/19/22 - 11:19 am

natural killer cells

Innate Pharma reports data from Phase II mycosis fungoides antibody trial

Clinical Trials Arena

Mon, 09/26/22 - 10:50 am

mycosis fungoides

clinical trials

Fresh disappointment for Innate’s Astra lifeline

EP Vantage

Mon, 08/1/22 - 10:41 am

clinical trials

ESMO 2021 movers – a handful of biotech winners emerge

EP Vantage

Fri, 09/24/21 - 11:48 am

Corbus Pharmaceuticals

Leap Therapeutics

Surface Oncology

Spectrum Pharrmaceuticals

Mirati Therapeutics

ESMO 2021 – Astra coasts towards a new lung cancer combo

EP Vantage

Mon, 09/20/21 - 10:54 pm

non-small cell lung cancer

FDA lifts partial hold on cancer drug after Innate resolves manufacturing issue

Endpoints

Wed, 06/24/20 - 10:52 am

clinical trials

drug manufacturing

Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO

Endpoints

Mon, 09/23/19 - 10:49 am

AstraZeneca gets rights, options to basket of next-gen immuno-oncology therapies from Innate

BioCentury

Tue, 10/23/18 - 11:02 pm

Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab

Endpoints

Sat, 11/25/17 - 12:32 pm

Bristol-Myers Squibb

acute myeloid leukemia